Sarepta Therapeutics | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 4.09B 483M 2025-08
Agios Pharmaceuticals USD 2B 66M 2025-08
Alnylam Pharmaceuticals USD 53.03B 10.5B 2025-08
Amgen USD 154.93B 4.8B 2025-08
Biogen USD 19.23B 818M 2025-08
BioMarin Pharmaceutical USD 10.92B 378M 2025-08
Daiichi Sankyo JPY 6.79T 412.01B 2025-08
Eli Lilly USD 615.07B 123.72B 2025-08
Gilead Sciences USD 147.49B 9.58B 2025-08
Incyte USD 17.01B 3.83B 2025-08
Insmed USD 16.76B 2.34B 2025-08
Ionis Pharmaceuticals USD 6.2B 94M 2025-08
Moderna USD 10.57B 101M 2025-08
Neurocrine Biosciences USD 12.83B 388M 2025-08
Pfizer USD 139.86B 2.34B 2025-08
PTC Therapeutics USD 3.48B 394M 2025-08
Regeneron Pharmaceuticals USD 62.39B 6.52B 2025-08
Sanofi EUR 101.06B 998.99M 2025-08
Sarepta Therapeutics USD 1.71B 30M 2025-08
Tectonic Therapeutic USD 681M 234M 2024-12
Ultragenyx Pharmaceutical USD 2.27B 1.17B 2025-08
Vertex Pharmaceuticals USD 97.65B 16.68B 2025-08


Sarepta Therapeutics Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.